Clinical Trial

A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
A Phase Ib Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-13.
Status change: Not Yet Recruiting → Recruiting 2025-04-01
Trial Details
NCT Number NCT06740019
Lead Sponsor Jemincare
Conditions Malignant Pleural Effusions (Mpe)
Enrollment 30 participants
Start Date 2024-12-28
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-04